TGFB1 and neoplasm: While the academic community has conducted in-depth research on the mechanisms by which biochemical signals such as those mediated by prostaglandin E2 (PGE2) and transforming growth factor-β (TGF-β) regulate tumor immunosuppression, the complex biophysical landscape of solid tumors poses an undeniable challenge to immunotherapy (2, 3).